Literature DB >> 31538216

Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations.

Yu Dong1, Guangsen Li2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver disease in developed countries and is associated with type 2 diabetes mellitus, obesity, hypertension, dyslipidemia, and metabolic syndrome. It is defined as steatosis in over 5% of hepatocytes. The disease spectrum of NAFLD ranges from simple fatty liver to nonalcoholic steatohepatitis, liver fibrosis, even hepatic cirrhosis. The disease affects various extra-hepatic systems such as the cardiovascular system and urinary system. Heart-related disease is identified as the leading cause of mortality in NAFLD patients rather than liver-related disease. In this review, we summarize the cardiac abnormalities (structural, functional, arrhythmic cardiac complications etc.) seen in NAFLD patients with the assistance of auxiliary examinations, such as electrocardiography, echocardiography, computed tomography, magnetic resonance imaging etc. In addition, the epidemiology of NAFLD and how NAFLD affects the myocardium are also discussed.

Entities:  

Keywords:  Cardiovascular disease; Computed tomography; Echocardiography; Electrocardiography; Steatosis

Mesh:

Year:  2019        PMID: 31538216     DOI: 10.1007/s00059-019-04855-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  71 in total

Review 1.  Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

Authors:  Amedeo Lonardo; Stefano Bellentani; Curtis K Argo; Stefano Ballestri; Christopher D Byrne; Stephen H Caldwell; Helena Cortez-Pinto; Antonio Grieco; Mariana V Machado; Luca Miele; Giovanni Targher
Journal:  Dig Liver Dis       Date:  2015-08-14       Impact factor: 4.088

Review 2.  The global NAFLD epidemic.

Authors:  Rohit Loomba; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

3.  Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166).

Authors:  Jian Gao Fan; Ji Dong Jia; You Ming Li; Bing Yuan Wang; Lun Gen Lu; Jun Pin Shi; Lik Yuen Chan
Journal:  J Dig Dis       Date:  2011-02       Impact factor: 2.325

4.  High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.

Authors:  Paola Portillo-Sanchez; Fernando Bril; Maryann Maximos; Romina Lomonaco; Diane Biernacki; Beverly Orsak; Sreevidya Subbarayan; Amy Webb; Joan Hecht; Kenneth Cusi
Journal:  J Clin Endocrinol Metab       Date:  2015-04-17       Impact factor: 5.958

Review 5.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

6.  Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver.

Authors:  Gianluca Perseghin; Guido Lattuada; Francesco De Cobelli; Antonio Esposito; Elena Belloni; Georgia Ntali; Francesca Ragogna; Tamara Canu; Paola Scifo; Alessandro Del Maschio; Livio Luzi
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

7.  Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.

Authors:  Shivaram Prasad Singh; Sachidananda Nayak; Manorama Swain; Niranjan Rout; R N Mallik; Omprakash Agrawal; Chudamani Meher; Mvk Rao
Journal:  Trop Gastroenterol       Date:  2004 Apr-Jun

Review 8.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

Review 9.  Non-alcoholic fatty liver disease: the mist gradually clears.

Authors:  Nimantha Mark Wilfred de Alwis; Christopher Paul Day
Journal:  J Hepatol       Date:  2008-02-04       Impact factor: 25.083

Review 10.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.